La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Vincerx Pharma a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Vincerx Pharma..

Vincerx Pharma (OTC:VINC) Azioni, Catena delle Opzioni

Vincerx Pharma

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.

VINCERX PHARMA INC by Vincerx Pharma, Inc.

Vincerx Pharma Inc

VINchain

Vince Holding Corp

Vinci Partners Investments Ltd. - Class A Common Shares

Vinci Partners Investments Ltd

Vinci SA

VINCO VENTURES INC by Vinco Ventures, Inc.

Vinco Ventures Inc

WIIM

Mercurity Fintech Holding shares are trading higher after the company announced a $800 million financing plan for a Bitcoin treasury reserve.

PETS

PetMed Express shares are trading lower after the company announced delays for its Q4 and FY25 earnings release.

Cabaletta Bio, Inc. ("Cabaletta" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CABA#NASDAQ">CABA</a>), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, announced that it has commenced an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock (or pre-funded warrants in lieu thereof) and, in lieu of common stock, to certain investors, pre-funded warrants to purchase shares of its common stock and accompanying warrants to purchase shares of its common stock (or pre-funded warrants in lieu thereof). Cabaletta also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock and warrants offered in the public offering. All of the shares, pre-funded warrants and accompanying common stock warrants to be sold in the proposed offering are to be sold by Cabaletta.

News

Offerings

CABA

Cabaletta Bio Earlier Announced Proposed Public Offering Of Securities

B of A Securities analyst Jason Zemansky maintains Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) with a Buy and raises the price target from $94 to $109.

Price Target

Analyst Ratings

INSM

B of A Securities Maintains Buy on Insmed, Raises Price Target to $109

KLTO

Klotho Neurosciences amends April 2022 Public Warrants to reprice exercise from $3.49 to $1.35.

UBS analyst Mark Carden maintains United Natural Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) with a Neutral and lowers the price target from $30 to $26.

UNFI

UBS Maintains Neutral on United Natural Foods, Lowers Price Target to $26

Inspira&#x2122; Technologies OXY B.H.N. Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IINN#NASDAQ">IINN</a>) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support and diagnostic technologies, announced today that its FDA-cleared ART100 system adoption has begun to positively impact commercialization interest and efforts, representing a key milestone and significantly contributes to the Company's commercial validation.
The ART100 system has been successfully integrated into real-world clinical workflows at leading tier-one U.S. hospitals over the past several months. Details of specific hospital deployments are subject to confidentiality, but reflect Tier-1 facilities in the U.S. This clinical use reflects growing confidence in the system's potential to support patients in critical condition and positions Inspira at the forefront of a rapidly evolving market of life-saving technologies.
The consistent use of the ART100 has prompted a wave of interest from additional U.S. and international healthcare institutions, as well as governmental authorities. The Company is currently engaged in commercial discussions with various stakeholders across multiple regions and is scaling up operational capabilities to support the anticipated adoption of the ART100.

Biotech

General

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

Inspira Technologies Sees Surge In Commercial Interest Following FDA-Cleared ART100 System Integration At Tier-1 U.S. Hospitals

Stock Split

CERO

CERo Therapeutics Holdings, Inc. Announces 1-For-20 Reverse Stock Split, Effective Jun. 13

Days after GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) revealed that it purchased 4,710 Bitcoins for its corporate treasury, Bitwise Asset Management rolled out an <a href="https://www.benzinga.com/etfs">options-only fund</a> aimed at transforming the wild volatility of the meme stock into a reliable income stream—without actually owning any shares.
As its prospectus outlines, the Bitwise GME Option Income Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGME#NYSE">IGME</a>) writes both call and put options on GameStop to capture option premiums. Its goal is to distribute those earnings to shareholders every month. 
This structure helps avoid directional risk while still allowing for exposure to the sharp price fluctuations that have turned GME into a favorite among retail traders.
IGME has an expense ratio of 0.98%, with the first distribution set for July 24. 
Also Read: <a href="https://www.benzinga.com/news/25/06/45872281/high-altitude-risk-archer-aviation-upstart-with-new-tradr-leveraged-etfs">High Altitude, Higher Risk: Tradr Launches Leveraged Plays On Archer Aviation, Upstart</a>
<h2 class="wp-block-heading">A Growing Suite Of Option-Based Funds </h2>
IGME marks Bitwise's fourth covered-call product launched in 2025, following similar offerings linked to MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), and others. 
The firm also manages the Bitwise Bitcoin ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>) and the Bitwise Ethereum ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETHW#NYSE">ETHW</a>), solidifying its status as a pioneer in crypto-related ETFs.
And timing matters. GameStop's choice to add bitcoin to its balance sheet introduces a new crypto angle to a stock already famous for its dramatic price swings driven by retail sentiment. By combining an options income strategy with this narrative, Bitwise places IGME at the crossroads of meme-stock volatility and corporate adoption of digital assets, an area that few other funds are currently exploring.
Analysts believe that Bitwise's latest offering could attract investors looking for a way to tap into GameStop's volatility and its crypto shift, all while preferring a risk-managed, income-focused approach.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45865293/microsoft-overtakes-nvidia-to-top-3-5-trillion-taking-these-3-etfs-with-it">Microsoft Overtakes Nvidia To Top $3.5 Trillion, Taking These 3 ETFs With It</a></li>
</ul>
Image: Shutterstock

New ETFs

ETFs

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

COIN

ETHW

Bitwise Funds Trust Bitwise GME Option Income Strategy ETF

IGME

MSTR

This New ETF Aims To Turn GameStop's Wild Moves Into Cash

Tempest Therapeutics, Inc. - Common Stock

TPST

Tempest Therapeutics shares are trading lower after the company announced a $4.6 million registered direct offering of 739,000 shares at $6.25 per share.

UBS analyst Arpine Kocharyan maintains Vail Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) with a Neutral and lowers the price target from $185 to $169.

UBS Maintains Neutral on Vail Resorts, Lowers Price Target to $169

B of A Securities analyst Peter Galbo maintains JM Smucker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) with a Neutral and lowers the price target from $118 to $105.

B of A Securities Maintains Neutral on JM Smucker, Lowers Price Target to $105

JZXN Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>, the ", Company", ))) announced that its board of directors has approved the issuance of convertible notes for fundraising. The funds will be exclusively used for Bitcoin strategic reserves, and upon receipt, 23.5 Bitcoins will be purchased as the initiation of the "Thousand Coins Plan" announced on May 22, 2025. The investors and investment conditions have been finalized, with the acquisition set to be completed shortly. This move signifies JZXN's U.S. subsidiary's entry into digital assets, demonstrating its confidence in Bitcoin's long-term value.
Per the Board resolution, JZXN will execute Bitcoin asset allocation progressively, with this initial acquisition constituting a core component of its thousand-Bitcoin strategy. The company emphasized Bitcoin's role as a flagship blockchain technology, noting its decentralized architecture, transparency, and security provide innovative options for asset diversification. By incorporating Bitcoin, JZXN aims to optimize its asset portfolio, enhance risk resilience, and capitalize on opportunities within the digital economy.
The convertible note offering represents a strategic decision aligned with current market dynamics and corporate objectives. JZXN will strictly comply with relevant laws, regulations, and supervisory requirements to ensure legitimate deployment of raised capital. While acknowledging Bitcoin's substantial investment potential, the company concurrently committed to maintaining prudent investment discipline to safeguard capital.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

JZXN

JZXN Holdings Approves Convertible Notes To Fund Bitcoin Reserves, Launches "Thousand Coins Plan" With Initial Purchase Of 23.5 BTC

Contracts

PDYN

Palladyne AI Receives Additional Funding From US Air Force Under Contract With Air Logistics Complex At Warner Robins Air Force Base

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">85.81</td>
<td align="right">0.75</td>
<td align="right">0.88</td>
<td>88.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">217.79</td>
<td align="right">1.36</td>
<td align="right">0.62</td>
<td>8.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">104.96</td>
<td align="right">0.24</td>
<td align="right">0.22</td>
<td>2.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">241.40</td>
<td align="right">0.53</td>
<td align="right">0.22</td>
<td>69.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">80.96</td>
<td align="right">0.10</td>
<td align="right">0.12</td>
<td>1.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">42.28</td>
<td align="right">0.05</td>
<td align="right">0.11</td>
<td>6.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">135.84</td>
<td align="right">0.16</td>
<td align="right">0.11</td>
<td>15.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">144.32</td>
<td align="right">0.15</td>
<td align="right">0.10</td>
<td>6.5K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">88.90</td>
<td align="right">-0.02</td>
<td align="right">-0.03</td>
<td>3.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.75</td>
<td align="right">-0.01</td>
<td align="right">-0.02</td>
<td>1.4K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For June 11, 2025

TOPP

Toppoint Holdings shares are trading higher after the company announced it entered into an MOU with Peru's Chancay Municipality to overhaul waste management.

UBS analyst Karl Keirstead maintains GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) with a Buy and lowers the price target from $85 to $73.

GTLB

UBS Maintains Buy on GitLab, Lowers Price Target to $73

To extend everyday payments, remittances, and 'PayFi' solutions to millions of users and merchants
NEW YORK, June 11, 2025 /PRNewswire/ -- PayPal today announced plans to make the PayPal USD (PYUSD) stablecoin available on the Stellar network pending regulatory approval by the New York State Department of Financial Services (NYDFS)1. Stellar is a blockchain designed for fast, low-cost payments and real-world utility. By potentially expanding to Stellar, PYUSD leverages the network's speed, low transaction costs, and ease of integration to enhance its utility for real-world payments, commerce, and micro-financing, offering an additional option to Ethereum and Solana.
PYUSD on Stellar can be used for fast, affordable cross-border payments and expanded access to essential financial services while bridging the digital and physical world with a vast array of on and off ramps. Users may also benefit from improved daily payment options and financing solutions such as working capital and business loans - use cases already thriving on the Stellar network - ultimately enabling a more seamless flow of value across global markets.

PYPL

PayPal To Launch PYUSD Stablecoin On Stellar Network Pending NYDFS Approval

LEXX

Lexaria Bioscience Corp. Completes Human Study GLP-1-H25-5 Comparing Oral DehydraTECH-liraglutide To Injected Saxenda-Branded Liraglutide; Says 'Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (&ldquo;AEs&rdquo;) as compared to injected liraglutide (Saxenda(R))'

Curtiss-Wright Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CW#NYSE">CW</a>) todayannounced it has been awarded an approximately $80 million firm-fixed-price Indefinite Delivery, Indefinite Quantity (IDIQ) contract by the United States Air Force (USAF) to provide its High-Speed Data Acquisition System (HSDAS) hardware and associated repair services. The contract covers Curtiss-Wright's full line of Flight Test Instrumentation (FTI) products and will support production platforms as well as future USAF development programs.
Under the agreement, Curtiss-Wright will provide its HSDAS aerospace instrumentation technology including High Speed Data Acquisition, Network, Recording, Gateway, RF, and Data Analysis Software (IADS&#xAE;) products and services. The sole-source contract provides products, enhancements, upgrades, repair services, field service, and technical support to the HSDAS equipment and is scheduled to run through March 2030.

Comments

Vincerx Pharma

Vincerx Pharma (VINC) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO